← Back to patent-cliff list
CAS 542-44-9
2,3-dihydroxypropyl palmitate
Codes: EC-18-001
Application context (from source-drug indications)
Atopic dermatitisMosedipimodCOVID-19Mosedipimod发热性中性粒细胞减少症MosedipimodStomatitisMosedipimodNeutropeniaMosedipimod
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Mosedipimod | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-acetoxy-3-(palmitoyloxy)propan-2-yl (9Z,12Z)-octadeca-9,12-dienoate→2,3-dihydroxypropyl palmitate→2-hydroxy-3-(trityloxy)propyl palmitate→(9Z,12Z)-octadeca-9,12-dienoic acid→1-(palmitoyloxy)-3-(trityloxy)propan-2-yl (9Z,12Z)-octadeca-9,12-dienoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.